BGC > Product Search > Cefepime dihydrochloride | 123171-59-5

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Molecular Formula: C19H24N6O5S2.2ClH.H2O
Molecular Weight: 571.5
Hazard Symbols: Xi
WGKGermany: 3
HS Code: 29419000

Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.

• Molecular Weight :571.50
• Melting Point :150°C(dec.)
• Purity :> 98%

Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime

More details are to be found here

Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.

• Molecular Weight :571.50
• Melting Point :150°C(dec.)
• Purity :> 98%

Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime

More details are to be found here

Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.

• Molecular Weight :571.50
• Melting Point :150°C(dec.)
• Purity :> 98%

Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime

More details are to be found here

Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.

• Molecular Weight :571.50
• Melting Point :150°C(dec.)
• Purity :> 98%

Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime

More details are to be found here

Description :
Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated.

• Molecular Weight :571.50
• Melting Point :150°C(dec.)
• Purity :> 98%

Molecular Formula :
C19H28Cl2N6O6S2
Canonical SMILES :
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
InChI :
InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1./s1
InChIKey :
LRAJHPGSGBRUJN-OMIVUECESA-N
Solubility :
Soluble in DMSO
Appearance :
White Solid
Storage : Store at -20°C
Synonyms :
Maxipime

More details are to be found here